Loading...
•
Mar 31, 2023
Acadia Healthcare Q1 2023 Earnings Report
Acadia Healthcare's Q1 2023 results were announced, demonstrating revenue growth and strategic advancements.
Key Takeaways
Acadia Healthcare reported a strong start to 2023 with a 14.2% increase in revenue, reaching $704.3 million. The company's net income attributable to Acadia was $66.0 million, or $0.72 per diluted share, and adjusted income from continuing operations was $68.7 million, or $0.75 per diluted share. Acadia is on track with its growth strategy, including facility expansions and new facility developments.
Revenue totaled $704.3 million, a 14.2% increase year-over-year.
Same facility revenue increased by 13.3% compared to Q1 2022.
Net income attributable to Acadia was $66.0 million, or $0.72 per diluted share.
Adjusted EBITDA totaled $151.3 million, an 11.6% increase year-over-year.
Forward Guidance
Acadia affirmed its previously announced financial guidance for 2023.
Positive Outlook
- Revenue: $2.82 to $2.88 billion
- Adjusted EBITDA: $635 to $675 million
- Adjusted earnings per diluted share: $3.10 to $3.40
- Operating cash flows $450 to $500 million
- Expansion capital expenditures $350 to $400 million
Challenges Ahead
- Interest expense: $80 to $85 million
- Tax rate: 25% to 26%
- Depreciation and amortization expense: $125 to $135 million
- Stock compensation expense: $30 to $35 million
- Maintenance capital expenditures $40 to $50 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...